Earnings Call · Q2 FY2022·2022-07-29

Q2 22EPS +1.81%·Rev n/aQ1 22EPS +0.64%·Rev n/aQ4 21EPS +0.91%·Rev n/aQ3 21EPS +3.42%·Rev n/a⚠ consensus missing

AbbVie Inc. ABBV

Liz Shea — Vice President, Head of Investor Relations

Rick Gonzalez — Chairman and Chief Executive Officer

Jeff Stewart — Executive Vice President, Chief Commercial Officer

Tom Hudson — Senior Vice President, R&D and Chief Scientific Officer

Rob Michael — Vice Chairman and President

−4.2%1d on move date−5.6% vs SPY3d−6.3%5d−7.2%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABBV calls or request research access.

More ABBV calls Browse calls Request research access